Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”. Throughout 2022, Novartis was at the opposing ends of legal cases.

Documentation 97

Documentation FDA Hospitals Dosage 97

Hospital Pharmacy Europe

JANUARY 4, 2023

The study included data on 79,658 women in the NHS, 93,932 in the NHS II and 31,440 men in the HPFS (2004-2016), without prior stroke or CHD. During >2 million person-years of follow-up, 3603 incident stroke and 8620 incident CHD cases were documented. Herpes Zoster and Long-Term Risk of Cardiovascular Disease. J Am Heart Assoc.

Medical Schools 52

Medical Schools Documentation Hospitals 52

Hospital Pharmacy Europe

JUNE 8, 2023

This suspicion was confirmed in a 2004 analysis by researchers from Oxford. They examined possible changes using three different methods: the history of tracked changes on ClinicalTrials.gov ; self-reported changes noted in the article; and changes reported within the protocol, including all available protocol documents.

Documentation 52

Documentation Communication Patient Care Hospitals 52

Hospital Pharmacy Europe

JULY 3, 2024

Given the pressures on inpatient care, notably bed capacity and blocking (bottlenecks in patients being able to leave the ED because of lack of capacity in the downstream system), moving pharmaceutical care closer to the hospital front door– that is, to the ED – is logical. ED pharmacy services were surveyed for the first time in 2004.

Hospitals 52

Hospitals Communication Patient Care Packaging 52

European Pharmaceutical Review

JULY 20, 2023

In addition to hospitals and blood transfusion centres, pharmaceutical, device and other companies involved with blood products and cell- and gene-therapy products are advised to closely monitor developments surrounding the proposed regulation. Strict requirements apply, especially with regard to traceability and coding. Cited 2023Mar].

Labelling 75

Labelling Documentation Hospitals 75

European Pharmaceutical Review

APRIL 14, 2025

The decentralised spectrum Decentralisation comes in different forms, such as at home, where a person makes a medicine in their home, for example using a consumer 3D printer, as well as point of care, where eg, a cancer medicine is manufactured in a facility located in proximity to where a patient is waiting for treatment, such as in hospital.

Hospitals 52

Hospitals Documentation Insurance Packaging 52

The People's Pharmacy

MAY 8, 2023

There have been problems with records in the past: deceit, falsification of documents and even outright fraud. drug supply and made their way to patients’ medicine cabinets, hospital supply closets and IV drips.” What is extraordinary about this scandal is that the FDA inspected one of the Ranbaxy facilities in 2004.

FDA 72

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools 72